Renal Cell Carcinoma

Showing 26 - 50 of 513

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023

Solid Tumor, Renal Cell Carcinoma, Von Hippel-Lindau Disease Trial in China (BPI-452080)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • Shanghai, Shanghai, China
  • +4 more
Apr 24, 2023

Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

Recruiting
  • Invasive Ductal Breast Carcinoma
  • +14 more
  • Stereotactic body radiotherapy
  • Lattice Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2023

Lung Non-Small Cell Carcinoma, Malignant Solid Tumor, Melanoma Trial in Duarte (procedure, other, radiation)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Apr 13, 2023

Renal Cell Carcinoma Trial in Kocaeli (preoperative remifentanil consumption, postopeartive controlled anlagesia with morphine)

Active, not recruiting
  • Renal Cell Carcinoma
  • preoperative remifentanil consumption
  • postopeartive controlled anlagesia with morphine
  • Kocaeli, Turkey
  • +1 more
Mar 31, 2023

Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma Trial in Chengdu (AK104, Axitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +3 more
  • Chengdu, Sichuan, China
    West China Hospital
Apr 10, 2023

Gastrointestinal Stromal Tumors, Renal Cell Carcinoma, Pancreatic Neuroendocrine Tumor Trial in Changchun (Sunitinib malate

Completed
  • Gastrointestinal Stromal Tumors
  • +2 more
  • Sunitinib malate capsules generic product
  • Sunitinib malate capsules reference product
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Apr 6, 2023

Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

Recruiting
  • Renal Cell Carcinoma
  • Beijing, China
  • +1 more
Mar 28, 2023

Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

Not yet recruiting
  • Renal Cell Carcinoma
  • Sodium Pentaborate
  • Tabriz, East Azarbayejan, Iran, Islamic Republic of
    Imam Reza hospital and Clinic of Salamat
Mar 23, 2023

NSCLC, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Duarte (JANX008)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 29, 2023

NSCLC, Gastric Cancer, Head Neck Cancer Trial (CDX-585)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +13 more
  • (no location specified)
Mar 29, 2023

Renal Cell Carcinoma, Melanoma, Non Small Cell Lung Cancer Trial (HFB200603, Tislelizumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • +4 more
  • (no location specified)
Mar 15, 2023

Biomarkers of Renal Cancer

Recruiting
  • Renal Cell Carcinoma
  • +3 more
    • Firenze, Italy
    • +3 more
    Mar 14, 2023

    Solid Tumor, Haematological Malignancy, Malignant Tumor Trial in United Kingdom (Alectinib)

    Recruiting
    • Solid Tumor
    • +10 more
    • Belfast, United Kingdom
    • +25 more
    Mar 14, 2023

    Melanoma, Renal Cell Carcinoma Trial in Hull (Zirconium 89Zr crefmirlimab berdoxam)

    Recruiting
    • Melanoma
    • Renal Cell Carcinoma
    • Zirconium 89Zr crefmirlimab berdoxam
    • Hull, United Kingdom
      Castle Hill Hospital
    Feb 15, 2023

    Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Neoadjuvant
    • Axitinib plus Toripalimab
    • radical nephrectomy
    • (no location specified)
    Feb 12, 2023

    Renal Cell Carcinoma, Adrenal Tumor, Nonfunctioning Kidney Trial (telesurgery by domestic surgical robot)

    Not yet recruiting
    • Renal Cell Carcinoma
    • +13 more
    • telesurgery by domestic surgical robot
    • (no location specified)
    Feb 12, 2023

    Renal Cell Carcinoma Trial in Philadelphia (Pembrolizumab infusion, Lenvatinib tablet)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pembrolizumab infusion
    • Lenvatinib tablet
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Feb 8, 2023

    Renal Cell Carcinoma Trial in Cleveland (Donor Radical and Partial Nephrectomy, Kidney Transplantation, Laparoscopic Radical

    Not yet recruiting
    • Renal Cell Carcinoma
    • Donor Radical and Partial Nephrectomy
    • +2 more
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Feb 15, 2023

    Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma Trial in United States (PRO1160)

    Not yet recruiting
    • Renal Cell Carcinoma
    • +2 more
    • Detroit, Michigan
    • +4 more
    Jan 31, 2023

    Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

    Not yet recruiting
    • Advanced Cancer
    • +16 more
    • Fosifloxuridine Nafalbenamide
    • +3 more
    • Birmingham, United Kingdom
    • +3 more
    Feb 1, 2023

    Develop Circulating Exosomes as Predictive Biomarkers for

    Recruiting
    • Renal Cell Carcinoma
    • Other: Blood and Urine Collection
    • Hangzhou, China
      An Zhao
    Jan 30, 2023

    Renal Cell Carcinoma Trial in Worldwide (Atezolizumab, Placebo)

    Completed
    • Renal Cell Carcinoma
    • Scottsdale, Arizona
    • +185 more
    Jan 30, 2023

    Advanced Solid Tumors, Lymphoma, Gastric Cancer Trial in United States (FT500, Nivolumab, Pembrolizumab)

    Completed
    • Advanced Solid Tumors
    • +17 more
    • San Diego, California
    • +3 more
    Jan 27, 2023

    Primary and Metastatic Tumors in Renal Cell Carcinoma and

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Immune checkpoint inhibitor targeting PD1
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    Jan 27, 2023